NCT03514732View on ClinicalTrials.gov

Study to Evaluate Improvements of the Quality of Sleep With NOVANUIT® Triple Action in Healthy Volunteers With Sleep Disorders

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 17, 2017

Primary Completion Date

July 5, 2017

Study Completion Date

July 5, 2017

Conditions
Sleep Disorder (Healthy Volunteers)
Interventions
DRUG

MELATONIN (MELATL07959)

Pharmaceutical form:Capsule Route of administration: Oral

Trial Locations (1)

Unknown

Sanofi Administrative Office, Gdansk

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY